The percentage of CD3+, CD4+, CD8+ and natural killer cells were determined by flow cytometry from the specimens biopsy before treatment and the results were then compared to the patient outcomeResults: The increased percentage of CD 4 T cell in the pretreatment biopsy specimens correlated to the patient outcome.